Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, United States.
Bioorg Med Chem. 2013 Jan 1;21(1):359-64. doi: 10.1016/j.bmc.2012.09.051. Epub 2012 Oct 22.
To expand on the antiviral properties of 5'-noraristeromycin, synthetic entry into 3-substituted 3-deaza-5'-noraristeromyin derivatives (i.e., bromo, 4; iodo, 5; chloro, 6; and, methyl, 7) has been accomplished from a common intermediate. An extensive antiviral analysis showed 7 to be basically inactive (except for weak effects against VSV) and there were no general trends among the halo compounds (except versus reovirus-1 and influenza B). Individually, compound 4 was most favorable towards HCMV, VZV, HBV, and VV; product 5 against HBV, VSV, VV, influenza B, HCMV, and measles; and, target 6 towards Punta Toro, VSV, measles, parainflucenza-3, influenza A (H5N1), and influenza B. The methyl target 7 was inactive in all viral assays.
为了扩展 5'-去氮阿糖肌苷的抗病毒特性,我们从一个共同的中间体合成了 3-取代的 3-去氮-5'-去氮阿糖肌苷衍生物(即溴代物 4、碘代物 5、氯代物 6 和甲基化物 7)。广泛的抗病毒分析表明 7 基本上没有活性(除了对 VSV 的微弱作用),卤代物之间也没有一般趋势(除了对呼肠孤病毒-1 和流感 B 之外)。单独来看,化合物 4 对 HCMV、VZV、HBV 和 VV 最有利;化合物 5 对 HBV、VSV、VV、流感 B、HCMV 和麻疹最有利;而靶标 6 对 Punta Toro、VSV、麻疹、副流感-3、甲型流感(H5N1)和流感 B 最有利。所有病毒检测中,甲基化靶标 7 均无活性。